Lauren Mastrocola - Nov 14, 2024 Form 4 Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Role
Principal Accounting Officer
Signature
/s/ Alex Nemiroff, as Attorney-in-Fact
Stock symbol
PRAX
Transactions as of
Nov 14, 2024
Transactions value $
-$175,263
Form type
4
Date filed
11/15/2024, 09:30 PM
Previous filing
Jul 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRAX Common Stock Options Exercise $249K +4.37K +68.06% $56.94 10.8K Nov 14, 2024 Direct
transaction PRAX Common Stock Sale -$424K -5.19K -48.04% $81.78 5.61K Nov 14, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRAX Stock Option (Right to Buy) Options Exercise $0 -4.37K -20.83% $0.00 16.6K Nov 14, 2024 Common Stock 4.37K $56.94 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $81.23 to $81.797. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
F2 The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the reporting person's continued service through each vesting date.

Remarks:

The transactions reported in this Form 4 were effected for estate planning purposes.